Hematology
Scientists at University of Copenhagen Describe Research in Hematology
Published in Cancer Weekly, April 26th, 2011
2011 APR 26 -- Data detailed in 'The JAK2 V617F somatic mutation, mortality and cancer risk in the general population' have been presented. "JAK2 V617F is present in the majority of patients with myeloproliferative cancer; however, its prevalence and clinical significance in the general population is unknown. We screened for presence of the mutation in 10,507 participants from the Copenhagen City Heart Study with up to 17.6 years of follow up," scientists in report.
"Prevalence of the mutation was 0.2% (n=18). All 18 mutation positives died during follow up corresponding to a multifactorially adjusted hazard ratio for early death of 3.0 (95%CI:1.9-4.9)....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2011-04-26)
More Articles from Cancer Weekly
- Central Nervous System
Data on Central Nervous System Discussed by Researchers at Beckman Research Institute - Health Care, Hospitals
Dr. Jeff Cao Awarded Canadian Association of Radiation Oncology CARO-ACRO and Elekta 2011 Research Fellowship - Pathology
Findings from National Cancer Institute Advance Knowledge in Pathology - Rectal Cancer
Investigators at University of Arizona Have Published New Data on Rectal Cancer - Breast
New Breast Study Findings Have Been Reported by Researchers at Nnamdi Azikiwe University - Colon Cancer
New Colon Cancer Data Have Been Reported by Researchers at University of Ferrara - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
